Global Radiotherapy-Induced Nausea and Vomiting Treatment Market Size, Share and Report Analysis By Drug Class (5-HT3 Receptor Antagonists, NK1 Receptor Antagonists, Corticosteroids, Dopamine Antagonists, Benzodiazepines, Cannabinoids, Combination Therapies), By Emetogenic Risk Level (Moderate Emetogenic Radiotherapy, High Emetogenic Radiotherapy, Low Emetogenic Radiotherapy, Minimal Emetogenic Radiotherapy), By Route of Administration (Oral, Intravenous, Transdermal, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals & Cancer Centers, Specialty Oncology Clinics, Ambulatory Care Centers, Homecare Settings), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035